Gene · 580
Papers4,139
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 4,139
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| IDR-targeting compounds suppress HPV genome replication via disruption of phospho-BRD4 association with DNA damage response factors. | Mol Cell | 2024 | 38103559 | PubTator, text mining | PubMed |
| Codonopsis pilosula polysaccharide alleviates rotenone-induced murine brain organoids death through downregulation of gene body DNA methylation modification in the ZIC4/PGM5/CAMTA1 axis. | Biochem Biophys Rep | 2024 | 38074999 | PubTator, text mining | PubMed |
| Clinical implications of incorporating genetic and non-genetic risk factors in CanRisk-based breast cancer risk prediction. | Breast | 2024 | 38061307 | PubTator, text mining | PubMed |
| Biological landscape and nanostructural view in development and reversal of oxaliplatin resistance in colorectal cancer. | Transl Oncol | 2024 | 38042134 | PubTator, text mining | PubMed |
| Pathogenic germline variants in non-BRCA1/2 homologous recombination genes in ovarian cancer: Analysis of tumor phenotype and survival. | Gynecol Oncol | 2024 | 38041901 | PubTator, text mining | PubMed |
| Spectrum of histopathologic findings in risk-reducing bilateral prophylactic mastectomy in patients with and without BRCA mutations. | Hum Pathol | 2024 | 38000681 | PubTator, text mining | PubMed |
| Interactome of intact chromatosome variants with site-specifically ubiquitylated and acetylated linker histone H1.2. | Nucleic Acids Res | 2024 | 37994785 | PubTator, text mining | PubMed |
| LncSEA 2.0: an updated platform for long non-coding RNA related sets and enrichment analysis. | Nucleic Acids Res | 2024 | 37986229 | PubTator, text mining | PubMed |
| Olaparib plus Durvalumab, with or without Bevacizumab, as Treatment in PARP Inhibitor-Naïve Platinum-Sensitive Relapsed Ovarian Cancer: A Phase II Multi-Cohort Study. | Clin Cancer Res | 2024 | 37939124 | PubTator, text mining | PubMed |
| Synergistic antitumor efficacy of rMV-Hu191 and Olaparib in pancreatic cancer by generating oxidative DNA damage and ROS-dependent apoptosis. | Transl Oncol | 2024 | 37871517 | PubTator, text mining | PubMed |
| Hereditary cancer testing in a diverse sample across three breast imaging centers. | Breast Cancer Res Treat | 2024 | 37861889 | PubTator, text mining | PubMed |
| Quantifying the Expanding Landscape of Clinical Actionability for Patients with Cancer. | Cancer Discov | 2024 | 37849038 | PubTator, text mining | PubMed |
| Long noncoding RNAs as versatile molecular regulators of cellular stress response and homeostasis. | Hum Genet | 2024 | 37782337 | PubTator, text mining | PubMed |
| Mosaic BRCA1 promoter methylation contribution in hereditary breast/ovarian cancer pedigrees. | J Med Genet | 2024 | 37748860 | PubTator, text mining | PubMed |
| Germline pathogenic variants in neuroblastoma patients are enriched in BARD1 and predict worse survival. | J Natl Cancer Inst | 2024 | 37688579 | PubTator, text mining | PubMed |
| BARD1 germline variants induce haploinsufficiency and DNA repair defects in neuroblastoma. | J Natl Cancer Inst | 2024 | 37688570 | PubTator, text mining | PubMed |
| Mechanism of PARP inhibitor resistance and potential overcoming strategies. | Genes Dis | 2024 | 37588193 | PubTator, text mining | PubMed |
| The ubiquitin codes in cellular stress responses. | Protein Cell | 2024 | 37470788 | PubTator, text mining | PubMed |
| Structural dynamics of clinically-reported VUS in the BARD1 ARD-BRCT region to predict the molecular basis of alterations. | J Biomol Struct Dyn | 2024 | 37418175 | PubTator, text mining | PubMed |
| Bridging Health Disparities: a Genomics and Transcriptomics Analysis by Race in Prostate Cancer. | J Racial Ethn Health Disparities | 2024 | 36810713 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/580/papers?page=14